The trial enrolled 76 children with severe IGFD and followed them for up to 8 years on twice-daily subcutaneous mecasermin administration, with growth velocity, height standard-deviation score, and adverse events as primary endpoints
This could be explained by differences in average reactivities of RCS and ROS and their half-life times
p53, as an effective oncogene, promotes ferroptosis mainly through the canonical and non-canonical pathways (Gnanapradeepan et al., 2022)
In endothelial cells, BPC-157 activates ERK1/2 signaling, enhancing proliferation, migration, and vascular tube formation through transcription factors including c-Fos, c-Jun, and Egr-1